Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
DENTSPLY SIRONA ( (XRAY) ) has issued an announcement.
On October 14, 2025, DENTSPLY SIRONA announced that the SEC has concluded its investigation, which began in May 2022, into the company’s financial reporting matters without recommending any enforcement action. This closure is seen as a significant and favorable development for the company, reflecting its cooperation with the SEC and potentially strengthening its position in the industry.
The most recent analyst rating on (XRAY) stock is a Hold with a $11.50 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
DENTSPLY SIRONA’s overall stock score is primarily impacted by its poor financial performance, characterized by declining revenue, profitability, and increased leverage. Technical analysis also indicates bearish momentum, with the stock trading below key moving averages and technical indicators suggesting further downside. While the valuation component offers some appeal due to a high dividend yield, the negative P/E ratio reflects underlying financial issues. The earnings call provided mixed insights, with some operational improvements but ongoing challenges in sales and profitability.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
DENTSPLY SIRONA Inc. operates in the dental industry, providing a wide range of dental products and technologies, including dental equipment and consumables. The company focuses on innovation and quality, serving dental professionals globally.
Average Trading Volume: 3,480,237
Technical Sentiment Signal: Sell
Current Market Cap: $2.36B
For detailed information about XRAY stock, go to TipRanks’ Stock Analysis page.